Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: Elmer who wrote (707)	2/1/2002 9:56:00 AM
From: kensusman	Read Replies (2) \| Respond to of 712

That's an interesting thought. CORR investors would, in my opinion, be much better off if MLNM had not decided to purchase CORR. I believe the price of CORR would be in the high 20's now. MLNM would be lower, but with the brisk sales of integrelin, MLNM looks better than it actually is. This is another example of shareholder value being ignored. In the few instances in which I have owned stock in a company that becomes absorbed, I sell the stock as soon as the spike is reached (if possible), because once the smoke clears the price usually falls. I may still buy CORR if it gets ridiculously low (14!) KS